BACKGROUND: Appearance of glandular breast tissue may be difficult to distinguish from fat tissue by palpation, especially in obese girls. To our knowledge, validation of the clinical assessment of pubertal breast stages by magnetic resonance imaging (MRI) has never been performed. Our objective was to report normative data of glandular breast tissue volume and validate the clinical evaluation of pubertal breast staging by MRI of breast tissue and to evaluate circulating reproductive hormone levels and estrogen-dependent transabdominal ultrasound (TAUS) parameters as markers of glandular breast tissue. METHODS: Glandular breast tissue volume quantified by MRI and breast stage evaluation was performed in 100 healthy peripubertal girls. Circulating levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), inhibin B, and estradiol were measured by immunoassays. Ovarian volume, uterine volume, and endometrial thickness were assessed by TAUS. RESULTS: Glandular breast tissue volume was positively associated with Tanner stages (r = 0.858, P < 0.001). The sensitivity and specificity of breast palpation to detect presence of glandular breast tissue using MRI as gold standard were 96 and 95%, respectively. The best parameters to distinguish prepubertal girls from girls with breast development were: LH (area under the curve (AUC) by receiver operating characteristic analysis = 0.871), inhibin B (AUC = 0.847) and estradiol (AUC = 0.830). CONCLUSION: Clinical palpation reliably detects the presence of glandular breast tissue.
BACKGROUND: Appearance of glandular breast tissue may be difficult to distinguish from fat tissue by palpation, especially in obesegirls. To our knowledge, validation of the clinical assessment of pubertal breast stages by magnetic resonance imaging (MRI) has never been performed. Our objective was to report normative data of glandular breast tissue volume and validate the clinical evaluation of pubertal breast staging by MRI of breast tissue and to evaluate circulating reproductive hormone levels and estrogen-dependent transabdominal ultrasound (TAUS) parameters as markers of glandular breast tissue. METHODS: Glandular breast tissue volume quantified by MRI and breast stage evaluation was performed in 100 healthy peripubertal girls. Circulating levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), inhibin B, and estradiol were measured by immunoassays. Ovarian volume, uterine volume, and endometrial thickness were assessed by TAUS. RESULTS: Glandular breast tissue volume was positively associated with Tanner stages (r = 0.858, P < 0.001). The sensitivity and specificity of breast palpation to detect presence of glandular breast tissue using MRI as gold standard were 96 and 95%, respectively. The best parameters to distinguish prepubertal girls from girls with breast development were: LH (area under the curve (AUC) by receiver operating characteristic analysis = 0.871), inhibin B (AUC = 0.847) and estradiol (AUC = 0.830). CONCLUSION: Clinical palpation reliably detects the presence of glandular breast tissue.
Authors: Annette Mouritsen; Marie Lindhardt Johansen; Christine Wohlfahrt-Veje; Casper P Hagen; Jeanette Tinggaard; Mikkel G Mieritz; Katrine Tefre de Renzy-Martin; Tue Soeborg; Eva Fallentin; Anders Juul; Katharina M Main Journal: Clin Endocrinol (Oxf) Date: 2014-02-15 Impact factor: 3.478
Authors: Shumei S Sun; Christine M Schubert; William Cameron Chumlea; Alex F Roche; Howard E Kulin; Peter A Lee; John H Himes; Alan S Ryan Journal: Pediatrics Date: 2002-11 Impact factor: 7.124
Authors: C Wohlfahrt-Veje; J Tinggaard; K Winther; A Mouritsen; C P Hagen; M G Mieritz; K T de Renzy-Martin; M Boas; J H Petersen; K M Main Journal: Eur J Clin Nutr Date: 2014-01-29 Impact factor: 4.016
Authors: M H Slaughter; T G Lohman; R A Boileau; C A Horswill; R J Stillman; M D Van Loan; D A Bemben Journal: Hum Biol Date: 1988-10 Impact factor: 0.553
Authors: K A Boisen; M Kaleva; K M Main; H E Virtanen; A-M Haavisto; I M Schmidt; M Chellakooty; I N Damgaard; C Mau; M Reunanen; N E Skakkebaek; J Toppari Journal: Lancet Date: 2004-04-17 Impact factor: 79.321
Authors: Susan Y Euling; Marcia E Herman-Giddens; Peter A Lee; Sherry G Selevan; Anders Juul; Thorkild I A Sørensen; Leo Dunkel; John H Himes; Grete Teilmann; Shanna H Swan Journal: Pediatrics Date: 2008-02 Impact factor: 7.124
Authors: Jeanette Tinggaard; Casper P Hagen; Anders N Christensen; Annette Mouritsen; Mikkel G Mieritz; Christine Wohlfahrt-Veje; Jørn W Helge; Thomas N Beck; Eva Fallentin; Rasmus Larsen; Rikke B Jensen; Anders Juul; Katharina M Main Journal: Pediatr Res Date: 2017-07-19 Impact factor: 3.756
Authors: Camilla Eckert-Lind; Alexander S Busch; Jørgen H Petersen; Frank M Biro; Gary Butler; Elvira V Bräuner; Anders Juul Journal: JAMA Pediatr Date: 2020-04-06 Impact factor: 16.193
Authors: Andre Madsen; Bjørg Almås; Ingvild S Bruserud; Ninnie Helen Bakken Oehme; Christopher Sivert Nielsen; Mathieu Roelants; Thomas Hundhausen; Marie Lindhardt Ljubicic; Robert Bjerknes; Gunnar Mellgren; Jørn V Sagen; Pétur B Juliusson; Kristin Viste Journal: J Clin Endocrinol Metab Date: 2022-06-16 Impact factor: 6.134
Authors: Christine Wohlfahrt-Veje; Jeanette Tinggaard; Anders Juul; Jorma Toppari; Niels E Skakkebæk; Katharina M Main Journal: J Endocr Soc Date: 2021-06-10